Gelatinase-responsive biodegradable targeted microneedle patch for abscess wound treatment of S. aureus infection

Int J Biol Macromol. 2023 Dec 31;253(Pt 8):127548. doi: 10.1016/j.ijbiomac.2023.127548. Epub 2023 Oct 19.

Abstract

Abscess wound caused by bacterial infection is usually difficult to heal, thus greatly affect people's quality of life. In this study, a biodegradable drug-loaded microneedle patch (MN) is designed for targeted eradication of S. aureus infection and repair of abscess wound. Firstly, the bacterial responsive composite nanoparticle (Ce6@GNP-Van) with a size of about 182.6 nm is constructed by loading the photosensitizer Ce6 into gelatin nanoparticle (GNP) and coupling vancomycin (Van), which can specifically target S. aureus and effectively shield the phototoxicity of photosensitizer during delivery. When Ce6@GNP-Van is targeted and enriched in the infected regions, the gelatinase secreted by the bacteria can degrade GNP in situ and release Ce6, which can kill the bacteria by generating ROS under laser irradiation. In vivo experiments show that the microneedle is basically degraded in 10 min after inserting into skin, and the abscess wound is completely healed within 13 d after applying Ce6@GNP-Van-loaded MN patch to the abscess wound of the bacterial infected mice with laser irradiation, which can simultaneously achieve the eradication of biofilm and subsequent wound healing cascade activation, showing excellent synergistic antibacterial effect. In conclusion, this work establishes a synergistic treatment strategy to facilitate the repair of chronic abscess wound.

Keywords: Abscess wound; Biodegradable microneedle; Photodynamic therapy.

MeSH terms

  • Abscess / drug therapy
  • Animals
  • Anti-Bacterial Agents / pharmacology
  • Humans
  • Methicillin-Resistant Staphylococcus aureus*
  • Mice
  • Photochemotherapy*
  • Photosensitizing Agents / pharmacology
  • Quality of Life
  • Staphylococcus aureus
  • Vancomycin / pharmacology

Substances

  • Photosensitizing Agents
  • Anti-Bacterial Agents
  • Vancomycin